AGEPHA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 20 Mar 2026)
What this means for you
Registered since 02 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88325857
- Registration number
- 6070487
- Mark type
- Stylized text
- Filed
- 05 Mar 2019
- Published for opposition
- 14 Jan 2020
- Registered
- 02 Jun 2020
- Attorney of record
- Jeffrey H. Handelsman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceuticals, namely, anti-infectives; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for ophthalmological use; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating allergies; Pharmaceutical agents for epidermis; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of gout; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations, namely, ophthalmological preparations; Pharmaceutical preparations, namely, preparations for prophylaxes and/or treatment of the cardiovascular system; Dietetic substances adapted for medical use
Owner
- MURRAY & POOLE ENTERPRISES LTD., GIBRALTAR, GI
- AGEPHA Pharma s.r.o., Senec, SK
- AGEPHA Pharma s.r.o., Senec, SK
- AGEPHA Pharma s.r.o., Senec, SK
Prosecution history
- 20 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 20 Mar 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 20 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Dec 2025 — TEAS SECTION 8 & 15 RECEIVED
- 02 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Mar 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 02 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 30 Apr 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Apr 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Apr 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Apr 2020 — USE AMENDMENT FILED
- 24 Apr 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Apr 2020 — TEAS STATEMENT OF USE RECEIVED
- 10 Mar 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jan 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED